Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism

Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism

Vall Hebron Institut de Recerca

Projects

Desarrollo de un tratamiento tópico (colirio) para la retinopatía diabética basado en la señalización de la vía del GLP-1

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual, Patricia Bogdanov Baruj
Funding agency: Instituto de Salud Carlos III
Funding: 177100
Reference: DTS15/00151
Duration: 01/01/2016 - 30/06/2018

European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Neurodegeneration as an early event in the Pathogenesis of Diabetic Retinopathy: A multicentric, prospective, phase II-III, open randomized controlled trial to assess the e

IP: Rafael Simó Canonge
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 30000
Reference: INT15/00126
Duration: 01/01/2016 - 31/12/2016

MOPEAD: Models Of Patient Engagement for Alzheimer’s Disease

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual
Funding agency: The Innovative Medicines Initiative
Funding: 79887.5
Reference: MOPEAD_IMI2015
Duration: 01/09/2016 - 31/12/2019

PRE-test-STROKE [Personalizing REperfusion Therapeutic Strategies in Stroke]

IP: Joan Montaner Villalonga
Collaborators: Eva Baldrich Rubio, Rafael Simó Canonge, Nuria Paz Torres Aguila
Funding agency: Instituto de Salud Carlos III
Funding: 836037.4
Reference: PMP15/00022
Duration: 01/01/2016 - 31/12/2019